Biological and Clinical Attributes of Sporothrix globosa, a Causative Agent of Sporotrichosis
Nallely Nava-Pérez,Lisset G Neri-García,Oscar E Romero-González,Joshua A Terrones-Cruz,Laura C García-Carnero,Héctor M Mora-Montes
DOI: https://doi.org/10.2147/IDR.S362099
2022-04-23
Infection and Drug Resistance
Abstract:Nallely Nava-Pérez, Lisset G Neri-García, Oscar E Romero-González, Joshua A Terrones-Cruz, Laura C García-Carnero, &ast Héctor M Mora-Montes &ast Departamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Guanajuato, 36050, Gto., México &astThese authors contributed equally to this work Correspondence: Laura C García-Carnero; Héctor M Mora-Montes, Departamento de Biología, División de Ciencias Naturales y Exactas, Campus Guanajuato, Universidad de Guanajuato, Noria Alta s/n, col. Noria Alta, C.P, Guanajuato, 36050, Gto., México, Tel +52 473-7320006 Ext. 8193, Fax +52 473-7320006 Ext. 8153, Email ; Sporotrichosis is an important subcutaneous mycosis with high prevalence and threat to human and animal health worldwide. Sporothrix schenckii, Sporothrix brasiliensis , and Sporothrix globosa are the main etiological agents of this disease; and even though many efforts have been made recently to understand the Sporothrix -host interaction, little is known about S. globosa , an underestimated species. This organism shows the lowest virulence among the members of the Sporothrix pathogenic clade and represents an important pathogenic agent due to its global distribution. Here, we offer a review with all the known information about S. globosa , including its genome and proteomic information, and compare it with S. schenckii and S. brasiliensis , to explain the differences observed among these species, in terms of virulence, the host immune response, and the antifungal sensitivity. Also, we provide the gene prediction of some S. globosa putative virulence factors. Keywords: antifungal drugs, fungal infection, host–fungus interplay, epidemiology, diagnosis, treatment Sporotrichosis is a human and animal fungal infection that affects the epidermis and subcutaneous tissues, having as etiological agent members of the Sporothrix genus. 1–3 The classical infection route is the traumatic conidia implantation when interacting with decaying vegetal tissues, thus it is considered as a sapronosis. 1 However, epidemic sporotrichosis outbreaks of domestic animals, in the last years, have revealed that the fungus can be transmitted by close contact between infected animals and human beings, and thus is now considered as a zoonosis too. 4–6 The Sporothrix genus currently contains at least 51 species and phylogenetic analyses have grouped them within different clades, from which the pathogenic clade contains most of the sporotrichosis etiological agents: Sporothrix schenckii, Sporothrix brasiliensis, Sporothrix globosa , and Sporothrix luriei . 7 The first three species are the most common ones associated with the disease, and S. schenckii was described and recognized as the causative agent of the disease more than a century ago, and thus it is currently the most studied species of the Sporothrix pathogenic clade. 1,3 S. brasiliensis has attracted attention in recent years because of the zoonotic outbreaks in Brazil, and most recently in Argentina, 1,8,9 affecting both domestic cats and human beings. 8,10 In the case of S. globosa , the species has been recently associated with both sapronotic and zoonotic outbreaks in Asia, and to a lesser extent in some parts of America. 11–13 This organism is the most underestimated and poorly study Sporothrix species; and thus far, no review papers dealing with both its basic and clinical aspects are available in the scientific literature. Therefore, in this review, we focused on highlighting the similarities and differences of S. globosa with other medically relevant Sporothrix species, in terms of basic biological aspects, clinical manifestations, diagnosis, and infection treatment. Although S. globosa is considered a cosmopolitan species, there are geographical areas where it is most frequently isolated, with a prevalence rate of 56% in Asia (China, India, and Japan), where it represents 99.3% of the total Sporothrix species in this region, 28% in Europe (Spain, Italy, and United Kingdom), 11% in America (Brazil, United States, Venezuela, Guatemala, Colombia, and Mexico), and 5% in Africa (South Africa) (Figure 1). 13–18 It has also been reported that all the strains found in India so far belong to S. globosa , and it is the second main species found in Australia. 19,20 Figure 1 Geographic distribution of Sporothrix globosa isolates. This species is mainly found in Asia (China, India, and Japan), followed by Europe (Spain, Italy, and United Kingdom), America (Brazil, Unite -Abstract Truncated-
pharmacology & pharmacy,infectious diseases